The WHO BPaLM Accelerator Platform was established in January 2023, right after the update of WHO guidelines on the treatment of drug-resistant TB in 2022. The purpose of the WHO BPaLM Accelerator Platform is to support countries and stakeholders in information exchange and technical discussions to address challenges in the adoption and implementation of the BPaLM/BPaL regimen. This is also to support the Call to Action on rolling out of the BPaLM regimen and other short regimens for treatment of TB that was initiated by WHO and its multiple partners.
The platform participants include broad representation from national TB programmes of high TB burden countries from all regions, civil society, technical and funding partners involved in the implementation of the BPaLM regimen and supporting TB care.
The WHO BPaLM Accelerator Platform virtual meetings are organized monthly, covering topics around implementation aspects of the BPaLM/BPaL regimen. The topics presented and discussed are suggested to benefit the platform participants and they usually are focusing on country experience sharing, implementation challenges and practical solutions, and frequently asked questions and answers. Presentations or interactive discussions are typically delivered by technical partners, civil society, or country representatives.
If you want to join the platform, please fill the subscription form and email it to [email protected].
